BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND CgA AND Clinical Outcome
3 results:

  • 1. Chromogranin A (cga) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.
    Liao LM; Zhang X; Ren YF; Sun XY; Di N; Zhou N; Pan RK; Ma SH; Zhou LX
    PLoS One; 2012; 7(4):e33674. PubMed ID: 22529895
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neuroendocrine differentiation in cervical carcinoma.
    Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
    J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.